Inhibition of thrombin generation by simvastatin and lack of additive effects of aspirin in patients with marked hypercholesterolemia
- 1 April 1999
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 33 (5) , 1286-1293
- https://doi.org/10.1016/s0735-1097(99)00023-6
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Increased thrombin generation and complement activation in patients with type IIA hyperlipoproteinemia: effects of simvastatin treatmentCurrent Therapeutic Research, 1997
- Vastatins Inhibit Tissue Factor in Cultured Human MacrophagesArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- No Influence of Simvastatin Treatment on Platelet Function In Vivo in Patients With HypercholesterolemiaArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine, 1996
- Inhibition of Thrombin Generation by Aspirin Is Blunted in HypercholesterolemiaArteriosclerosis, Thrombosis, and Vascular Biology, 1996
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995
- Aspirin as an Antiplatelet DrugNew England Journal of Medicine, 1994
- Lovastatin decreases plasma and platelet cholesterol levels and normalizes elevated platelet fluidity and aggregation in hypercholesterolemic patientsMetabolism, 1994
- Redirection of prostaglandin endoperoxide metabolism at the platelet-vascular interface in man.Journal of Clinical Investigation, 1989
- THROMBOXANE A2 IN SKIN-BLEEDING-TIME BLOOD AND IN CLOTTED VENOUS BLOOD BEFORE AND AFTER ADMINISTRATION OF ACETYLSALICYLIC ACIDThe Lancet, 1983